<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="159664">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01774994</url>
  </required_header>
  <id_info>
    <org_study_id>MEC04-021.3</org_study_id>
    <nct_id>NCT01774994</nct_id>
  </id_info>
  <brief_title>Arginine and Nitric Oxide (NO) Metabolism in Healthy Human Volunteers</brief_title>
  <official_title>Arginine and Nitric Oxide (NO) Metabolism in Healthy Human Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of arginine and NO metabolism in healthy subjects is important as a reference
      for alterations in arginine-NO metabolism in patients. Moreover, this study will indicate
      the changes during aging and gender-related differences. Although data on arginine
      metabolism exist in literature, data are limited to young healthy male subjects. Since
      patients with suspected changes in arginine metabolism, e.g. sepsis and cancer patients are
      often elderly and also women, knowledge of arginine metabolism in these groups is needed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">January 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>whole body NO synthesis</measure>
    <time_frame>2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>postabsorptive nitric oxide synthesis measured by using stable isotope methodology</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>whole body protein metabolism</measure>
    <time_frame>2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>postabsorptive whole body protein metabolism (protein synthesis, breakdown, net protein breakdown) measured by using stable isotope methodology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>whole body arginine metabolism</measure>
    <time_frame>2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>postabsorptive arginine metabolism measured by using stable isotope methodology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood parameters</measure>
    <time_frame>2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>postabsorptive blood levels (glucose, insulin, urea, amino acids, CRP)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>stable isotopes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>stable isotope infusion for measurement of metabolism</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>stable isotope infusion for measurement of metabolism</intervention_name>
    <arm_group_label>stable isotopes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Age 18-25 years (young); 50-70 years (middle aged/elderly)

        Exclusion Criteria:

          -  Diabetes mellitus type I

          -  Livercirrhosis, pancreatitis, malignancies

          -  Hypertension (diastolic blood pressure &gt;95 mmHg or systolic blood pressure &gt;160 mmHg)

          -  History of gastrointestinal complaints

          -  Recent involuntary weight loss (more than 10 % in 6 months or more than 5 % in one
             month)

          -  Pregnancy (pregnancy test is done in female subjects)

          -  Use of medication that can affect arginine metabolism (nitrovasodilators and
             corticosteroids)

          -  Subjects with &quot;high activity level&quot;
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolaas E Deutz, MD PhD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <reference>
    <citation>Luiking YC, Ten Have GA, Wolfe RR, Deutz NE. Arginine de novo and nitric oxide production in disease states. Am J Physiol Endocrinol Metab. 2012 Nov 15;303(10):E1177-89. doi: 10.1152/ajpendo.00284.2012. Epub 2012 Sep 25.</citation>
    <PMID>23011059</PMID>
  </reference>
  <reference>
    <citation>Luiking YC, Engelen MP, Deutz NE. Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care. 2010 Jan;13(1):97-104. doi: 10.1097/MCO.0b013e328332f99d. Review.</citation>
    <PMID>19841582</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 23, 2013</lastchanged_date>
  <firstreceived_date>January 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>volunteers</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
